CABP7 antibody (N-Term)
Quick Overview for CABP7 antibody (N-Term) (ABIN783667)
Target
See all CABP7 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human, mouse, rat
-
Purification
- Affinity chromatography purified via peptide column
-
Immunogen
- 15 amino acid peptide near the amino terminus of human CaBP7
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Store the antibody (in aliquots) at -20 °C.
-
-
- CABP7 (Calcium Binding Protein 7 (CABP7))
-
Alternative Name
- CABP7
-
Background
- Calcium binding proteins (CaBP) play a crucial role in the calcium-mediated cellular signal transduction pathway in the central nervous system. The CaBP family shares much similarity with CaM I (calmodulin), and it has been shown that CaBP proteins can substitute functionally for, and possibly augment the function of, CaM I. CaBP7 (Calcium-binding protein 7), contains two EF-hand domains for calcium binding and shares 70 % homology with CaBP8 and 50 % homology with CaM I. It negatively regulates Golgi-to-plasma membrane trafficking by interacting with PI4KB and inhibiting its activity. CaBP7 and 8 possess a targeting mechanism that is unique amongst the CaBPs that may contribute to differential functional Ca2+-sensing by these family members.Synonyms: Calcium-binding protein 7
-
Gene ID
- 164633
-
NCBI Accession
- NP_872333
-
UniProt
- Q86V35
Target
-